BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 17481544)

  • 1. Local recurrence of ductal carcinoma in situ after skin-sparing mastectomy.
    Carlson GW; Page A; Johnson E; Nicholson K; Styblo TM; Wood WC
    J Am Coll Surg; 2007 May; 204(5):1074-8; discussion 1078-80. PubMed ID: 17481544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.
    Boyages J; Delaney G; Taylor R
    Cancer; 1999 Feb; 85(3):616-28. PubMed ID: 10091735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of intraoperative gross examination of surgical margin status in women undergoing partial mastectomy for breast malignancy.
    Balch GC; Mithani SK; Simpson JF; Kelley MC
    Am Surg; 2005 Jan; 71(1):22-7; discussion 27-8. PubMed ID: 15757052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience.
    Padmore RF; Fowble B; Hoffman J; Rosser C; Hanlon A; Patchefsky AS
    Cancer; 2000 Mar; 88(6):1403-9. PubMed ID: 10717623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin-sparing mastectomy and immediate reconstruction is an acceptable treatment option for patients with high-risk breast carcinoma.
    Downes KJ; Glatt BS; Kanchwala SK; Mick R; Fraker DL; Fox KR; Solin LJ; Bucky LP; Czerniecki BJ
    Cancer; 2005 Mar; 103(5):906-13. PubMed ID: 15651068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ductal carcinoma in situ. The success of breast conservation therapy: a shared experience of two single institutional nonrandomized prospective studies.
    Lagios MD; Silverstein MJ
    Surg Oncol Clin N Am; 1997 Apr; 6(2):385-92. PubMed ID: 9115503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do sentinel node micrometastases predict recurrence risk in ductal carcinoma in situ and ductal carcinoma in situ with microinvasion?
    Murphy CD; Jones JL; Javid SH; Michaelson JS; Nolan ME; Lipsitz SR; Specht MC; Lesnikoski BA; Hughes KS; Gadd MA; Smith BL
    Am J Surg; 2008 Oct; 196(4):566-8. PubMed ID: 18760400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of local treatment on the recurrence rate of ductal carcinoma in situ.
    Warneke J; Grossklaus D; Davis J; Stea B; Bebb G; Taylor C; Hastings R; Villar H
    J Am Coll Surg; 1995 Jun; 180(6):683-8. PubMed ID: 7773481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatment.
    Petit JY; Veronesi U; Orecchia R; Luini A; Rey P; Intra M; Didier F; Martella S; Rietjens M; Garusi C; DeLorenzi F; Gatti G; Leon ME; Casadio C
    Breast Cancer Res Treat; 2006 Mar; 96(1):47-51. PubMed ID: 16261402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery.
    Boland GP; Chan KC; Knox WF; Roberts SA; Bundred NJ
    Br J Surg; 2003 Apr; 90(4):426-32. PubMed ID: 12673743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late results of skin-sparing mastectomy followed by immediate breast reconstruction.
    Meretoja TJ; Rasia S; von Smitten KA; Asko-Seljavaara SL; Kuokkanen HO; Jahkola TA
    Br J Surg; 2007 Oct; 94(10):1220-5. PubMed ID: 17579346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nipple-sparing mastectomy for breast cancer and risk reduction: oncologic or technical problem?
    Sacchini V; Pinotti JA; Barros AC; Luini A; Pluchinotta A; Pinotti M; Boratto MG; Ricci MD; Ruiz CA; Nisida AC; Veronesi P; Petit J; Arnone P; Bassi F; Disa JJ; Garcia-Etienne CA; Borgen PI
    J Am Coll Surg; 2006 Nov; 203(5):704-14. PubMed ID: 17084333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scientific Presentation Award. Patterns of local breast cancer recurrence after skin-sparing mastectomy and immediate breast reconstruction.
    Vaughan A; Dietz JR; Aft R; Gillanders WE; Eberlein TJ; Freer P; Margenthaler JA
    Am J Surg; 2007 Oct; 194(4):438-43. PubMed ID: 17826052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
    Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
    Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of ductal carcinoma in situ (DCIS). The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists.
    CMAJ; 1998 Feb; 158 Suppl 3():S27-34. PubMed ID: 9484276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Breast reconstruction after skin-sparing mastectomy or nipple-sparing mastectomy for breast cancer].
    Chen J; Lü Q; Wang X; Li H; Chen Y; Yang X; Zeng H
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jul; 27(7):872-5. PubMed ID: 24063181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin-sparing mastectomy and immediate breast reconstruction: incidence of recurrence in patients with invasive breast cancer.
    Fersis N; Hoenig A; Relakis K; Pinis S; Wallwiener D
    Breast; 2004 Dec; 13(6):488-93. PubMed ID: 15563856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of local recurrence following excision alone for ductal carcinoma in situ.
    Hetelekidis S; Collins L; Silver B; Manola J; Gelman R; Cooper A; Lester S; Lyons JA; Harris JR; Schnitt SJ
    Cancer; 1999 Jan; 85(2):427-31. PubMed ID: 10023711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An attempt to independently verify the utility of the Van Nuys Prognostic Index for ductal carcinoma in situ.
    MacAusland SG; Hepel JT; Chong FK; Galper SL; Gass JS; Ruthazer R; Wazer DE
    Cancer; 2007 Dec; 110(12):2648-53. PubMed ID: 17960606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.